Eastman Kodak has announced that it has secured a $765 million loan from the U.S. Government to support the launch of Kodak Pharmaceuticals, a new arm of the company that will produce critical pharmaceutical components in support of the US response to the coronavirus pandemic. According to the Wall Street Journal, Kodak will soon play a role in curbing the US’ reliance on medicines from outside sources like China – starting with producing active ingredients for generic drugs. Kodak chief exec Jim Continenza told the WSJ he expects basic pharma ingredients to eventually make up 30% to 40% of the company’s overall business. Learn More